Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)
Titel:
Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)
Auteur:
Pinto, C. Di Fabio, F. Siena, S. Cascinu, S. Rojas Llimpe, F.L. Ceccarelli, C. Mutri, V. Giannetta, L. Giaquinta, S. Funaioli, C. Berardi, R. Longobardi, C. Piana, E. Martoni, A.A.